Alloy Therapeutics
The Molecular Biologist will join the GEO team at Alloy Therapeutics in Cambridge, designing and constructing large-scale synthetic gene loci using advanced genome engineering techniques. The role involves hands‑on experimental work to develop and characterize transgenic platforms that support therapeutic antibody discovery, collaborating with internal and external partners.
Headquarters
Lexington, Massachusetts, United States
Company Size
51-200 employees
Founded
2017
Alloy Therapeutics is a fully integrated Product Development Organization (PDO) that partners with biotech, pharma, academic, and sovereign organizations to advance drug discovery and development across multiple modalities, including antibodies and multispecifics, TCR mimics, genetic medicines, pharmacology, and cell therapies. The company leverages proprietary AI/ML platforms, real-world data, and tech-enabled services spanning discovery through clinical development to deliver therapeutics with speed and capital efficiency. Alloy also operates specialized subsidiaries, including 82VS for asset-centric venture building and Spannerwerks for early clinical development support.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alloy Therapeutics.
Alloy Therapeutics didn’t post a salary, so this is our estimate from similar listings.
36% below the average for this role